Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > QGEN Qiagen NV > Detailed Quotes

QGEN Qiagen NV

41.280
+0.060+0.15%
Close 09/30 16:00 ET
41.2800.0000.00%
Post Mkt Price 09/30 16:00 ET
High
42.300
Open
41.390
Turnover
34.79M
Low
41.260
Pre Close
41.220
Volume
836.41K
Market Cap
9.40B
P/E(TTM)
18.59
52wk High
58.000
Shares
227.69M
P/E(Static)
18.68
52wk Low
40.490
Float Cap
9.31B
Bid/Ask %
0.00%
Historical High
59.000
Shs Float
225.64M
Volume Ratio
0.94
Historical Low
3.013
Dividend TTM
--
Div Yield TTM
--
P/B
2.86
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.37%
Amplitude
2.52%
Avg Price
41.595
Lot Size
1
Float Cap
9.31B
Bid/Ask %
0.00%
Historical High
59.000
Shs Float
225.64M
Volume Ratio
0.94
Historical Low
3.013
Dividend TTM
--
P/B
2.86
Dividend LFY
--
Turnover Ratio
0.37%
Amplitude
2.52%
Avg Price
41.595
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
QIAGEN NV is a provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The firm automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D, and industrial applications, primarily forensics). The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.
CEO: Mr. Thierry Bernard
Market: NYSE
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...